Skip to content

Home / News / Kindeva Appoints Mike Cowhig as Chief Legal Officer

Kindeva Appoints Mike Cowhig as Chief Legal Officer

March 9, 2026

Organizational

9TH MARCH 2026: Kindeva, a global drug delivery contract development and manufacturing organization (CDMO), has today announced the appointment of Mike Cowhig to the role of Chief Legal Officer, to drive legal strategy, enterprise risk management and corporate governance across the organization.

Bringing over 25 years of experience in the life sciences industry, Mike has previously held several Senior Leadership positions, including divisional General Counsel, highlighting his extensive expertise in successfully managing large-scale manufacturing projects across diverse markets whilst upholding the highest ethical business practices.

As part of his role, Mike will be responsible for aligning legal initiatives with Kindeva’s growth objectives, nurturing customer relations, and providing legal counsel for business-critical challenges. In addition to evolving Kindeva’s compliance program in the face of regulatory changes and managing all aspects of global corporate governance. 

“Having previously worked closely with a diverse range of organizations with complex operations, I have a great insight into the commercial and governance risks associated with contract manufacturing,” Mike said of the appointment. “Deeply understanding Kindeva’s customers whilst fostering a culture grounded in quality and trust will be essential to ensuring our high-performing legal and compliance teams continue to set new standards across the sector.”

David Stevens, CEO of Kindeva, commented on the story: “Kindeva operates at the forefront of highly regulated drug–device manufacturing, and strong legal leadership is essential to our continued success. Mike brings the expertise, strategic judgement, and integrity needed to advance our global legal and compliance functions while supporting our long‑term growth ambitions. I look forward to partnering closely with him as we pursue Kindeva’s mission and further strengthen the foundation for sustainable success.”

Share article:

Related news

Explore more of our latest news and announcements, where the demands of today meet the possibilities of tomorrow.

Kindeva Announces Leadership Transition to Drive Strategic Growth

Woodbury, Minnesota – January 15, 2026 – Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, today announced a series of planned leadership transitions designed to position the company for accelerating growth in its core businesses focused on parenteral and inhaled drug delivery.  Effective January 1, 2026, David Stevens, most recently […]

Learn More

Kindeva announces the appointment of David Stevens as President

Woodbury, Minnesota – 24 October 2025 – Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, announced the promotion of David Stevens, Chief Operating and Commercial Officer, to the newly created role of President. In this capacity, David will lead Kindeva’s global operations. With over 20 years of experience in the […]

Learn More

Kindeva appoints Joanna Disley as VP, Brand Strategy

Kindeva, a global CDMO and drug delivery expert, has today announced the appointment of Joanna Disley as VP, Brand Strategy to drive its brand, marketing and communications strategy. In this pivotal role, Joanna will be responsible for driving Kindeva’s overall brand, marketing and communications strategy. Joanna has extensive experience in marketing and communications which includes […]

Learn More

Kindeva bolsters executive team with Chief Quality Officer appointment

ST.LOUIS, 22nd APRIL:  Kindeva, a global CDMO and drug delivery expert, has today announced the appointment of Melanie Cerullo as Chief Quality Officer to drive its quality, compliance and regulatory strategy. With a proven track record in safely delivering treatments to patients across the globe, Melanie’s appointment will bolster the organization to deliver strategic value […]

Learn More

Kindeva Appoints Daniel J. Speciale as the New Chief Financial Officer (CFO)

LOUIS, Mo. and WOODBURY, Minn., Mar. 31, 2025 – Kindeva, a global CDMO and drug delivery expert, has appointed Daniel J. Speciale as Chief Financial Officer (CFO) to strengthen its executive leadership team and drive financial strategy across the  organization. As Kindeva continues its growth trajectory, Mr. Speciale will oversee all financial  functions, ensuring strong […]

Learn More

Kindeva Drug Delivery appoints new CIO to lead digital transformation business initiatives

ST. LOUIS and WOODBURY; NOV 12 2024 –Kindeva Drug Delivery, a global CDMO and drug delivery expert, has appointed Prakash Pandian as Chief Information Officer (CIO) to bolster its executive leadership team and power technological initiatives across the organization. As Kindeva continues its digital transformation journey, Prakash will be responsible for a host of technology-enabled initiatives […]

Learn More

John Patton, Head of Kindeva Drug Delivery’s Scientific Advisory Board, named winner of RDD Conference’s Charles G. Thiel Award

Award for Outstanding Research and Discovery in Respiratory Drug Delivery WOODBURY, Minn. and ST. LOUIS, Mo.; May 8, 2024 (Business Wire) – At the recent Respiratory Drug Delivery (RDD) Conference, John Patton, Ph.D., biotechnology scientist and entrepreneur and Head of the Scientific Advisory Board (SAB) for Kindeva Drug Delivery (KDD), a global leader in drug-device […]

Learn More

Kindeva Drug Delivery welcomes Jennifer Riter, new Vice President of Analytical Services

WOODBURY, Minn. and ST. LOUIS, Mo.; March 18, 2024 (Business Wire) – Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today welcomes Jennifer Riter as Vice President of Analytical Services to head up the recently announced analytical services global business unit. Riter comes to Kindeva from West Pharmaceutical where she spent the past […]

Learn More

Kindeva Drug Delivery appoints Brian Schubmehl as Chief Human Resources Officer

WOODBURY, Minn. and ST. LOUIS, Mo.; Sept. 15, 2023 (Business Wire) — Kindeva Drug Delivery (Kindeva), a premier global drug delivery device contract development and manufacturing organization (CDMO), announced that Brian Schubmehl has joined the company as Chief Human Resources Officer. Schubmehl brings more than two decades of diverse and senior global leadership expertise that has […]

Learn More

Manufacturing More Tomorrows™

Partner with us and benefit from a team with technical expertise and a passion for purpose. As a true partner, strategically minded and dedicated to your lasting legacy, we provide customized solutions tailored to your precise requirements. From development to commercial manufacturing and beyond, our CDMO solutions are designed to help your product progress with purpose.